Skip to content
HomeLatest newsOur heritageMosquitoons: The innovative mosquito repellent Johnson & Johnson sold over a century ago
Mosquitoons 1902

Mosquitoons: The innovative mosquito repellent Johnson & Johnson sold over a century ago

Buzzz. It’s a familiar warm-weather nuisance: mosquitoes. In the early 1900s, the pests also transmitted serious diseases, so the company produced an in-home fumigator designed to repel the insects.

Summer is traditionally a time for beach days, barbecues, late sunsets and that other harbinger of the season—mosquitoes.

Today, the insects are mostly an annoyance for the majority of people living in the U.S., where the risk of contracting the Zika virus is thankfully low. But at the turn of the 20th century, mosquitoes were a serious public health concern in America, when diseases like malaria were a problem, and antibiotics and vaccines weren’t readily available.

At the time, window screens were the main way people could keep mosquitoes out, but they provided less than adequate protection.

Enter Mosquitoons: an in-home disinfectant fumigator that Johnson & Johnson introduced in 1902.

“The product was designed to kill mosquitoes and the germs they carried into the house,” explains company historian Margaret Gurowitz.

The kit contained small candles that could be set on a plate, and the fumes produced would eliminate disease-carrying insects or drive them away.

Mosquitoons was one of many in-home fumigators that were sold at the time, enabling consumers to take action to help keep their families healthy—a mission Johnson & Johnson carries forth to this day.

When you’ve been innovating for over 135 years …

Johnson & Johnson has a virtual museum where you can learn more fun facts about its rich history.
Johnson & Johnson's new museum at its world headquarters in New Jersey
© Albert Vecerka/Esto. All rights reserved.

More from Johnson & Johnson

How Johnson & Johnson is fighting medical counterfeiting

Fake medication and compromised devices are part of a global market that poses a significant threat to the health of patients. Here’s how the company’s Global Brand Protection team helps keep people safe.

What are cataracts?

If you can’t read a screen without jacking up the brightness level or if night driving leaves you seeing fuzzy halos around traffic lights, you may among the 20 million U.S. adults who develops a cataract—the most common cause of vision loss worldwide. Luckily a simple surgical procedure can have you viewing the world in crisp, bright color again. Here’s what to know about cataract symptoms and removal.

Meet two brothers who are revolutionizing the way scientists develop treatments for cancer

Justin and Colin Farlow share how their next-generation cell and gene therapies are helping Johnson & Johnson in its quest to get in front of cancer.